Birgit Paul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Birgit Paul has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Julia Hufenbach
Institute for Complex Materials, Leibniz IFW Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
5 shared publications - Konrad Kosiba
Leibniz Institute for Solid State and Materials Research
3 shared publications - Martin Otto
Leibniz Institute for Solid State and Materials Research (IFW) 01069 Dresden Germany
3 shared publications - Annett Gebert
Institute for Complex Materials, Leibniz IFW Dresden, Helmholtzstraße 20, 01069 Dresden, Germany
2 shared publications - Michael Gelinsky
Centre for Translational Bone, Joint and Soft Tissue Research, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
2 shared publications - Amin Bahrami
Leibniz Institute for Solid State and Materials Research Dresden
1 shared publication
Latest Publications
- Open Access
- 13 February 2025
- Published by Wiley in Advanced Materials Interfaces
- Vol. 12 (11)
Atomic Layer Deposition of ZnO Coating on Biodegradable Fe‐Based Alloys
As implant‐related infections increase with a simultaneously increasing demand for implants, new material design concepts are needed to prevent such occasions from leading to failure or mortality. One approach is the antibacterial coating of implant materials with ZnO. This study applies ZnO by atomic layer deposition (ALD) on the novel class of temporary metallic implant materials. The biodegradable alloy Fe69Mn30C1 is applied as substrate. Three different coating thicknesses (33, 45, and 60 nm) deposited at the very low temperature of 100 °C are investigated regarding their mechanical behavior, roughness, wettability and in vitro degradation. With increasing thickness of the ALD coating, the roughness and corresponding contact angle slightly increased, although the surface remained hydrophilic. Initial corrosion products are analyzed by X‐ray photoelectron spectroscopy, where Zn with Phosphorous‐Oxygen compounds are identified. Furthermore, the antibacterial effect of a ZnO coating is tested against Gram‐positive Staphylococcus aureus compared to uncoated Fe69Mn30C1 and clinically applied 316L stainless steel. The ZnO coating clearly enhanced the antibacterial effect in direct material contact with S. aureus, inhibitory rate of up to 99.2% compared to uncoated 316L. As an outlook for further studies, it is demonstrated that an additively manufactured generic 3D structure can be coated using ALD.
- 13 February 2025
- Published by Wiley in Advanced Materials Interfaces
- Vol. 12 (11)
Open AccessAtomic Layer Deposition of ZnO Coating on Biodegradable Fe‐Based Alloys
As implant‐related infections increase with a simultaneously increasing demand for implants, new material design concepts are needed to prevent such occasions from leading to failure or mortality. One approach is the antibacterial coating of implant materials with ZnO. This study applies ZnO by atomic layer deposition (ALD) on the novel class of temporary metallic implant materials. The biodegradable alloy Fe69Mn30C1 is applied as substrate. Three different coating thicknesses (33, 45, and 60 nm) deposited at the very low temperature of 100 °C are investigated regarding their mechanical behavior, roughness, wettability and in vitro degradation. With increasing thickness of the ALD coating, the roughness and corresponding contact angle slightly increased, although the surface remained hydrophilic. Initial corrosion products are analyzed by X‐ray photoelectron spectroscopy, where Zn with Phosphorous‐Oxygen compounds are identified. Furthermore, the antibacterial effect of a ZnO coating is tested against Gram‐positive Staphylococcus aureus compared to uncoated Fe69Mn30C1 and clinically applied 316L stainless steel. The ZnO coating clearly enhanced the antibacterial effect in direct material contact with S. aureus, inhibitory rate of up to 99.2% compared to uncoated 316L. As an outlook for further studies, it is demonstrated that an additively manufactured generic 3D structure can be coated using ALD.
- Open Access
- 20 July 2024
- Published by Elsevier in Optics & Laser Technology
- Vol. 180
Fabrication of filigree parts via laser powder bed fusion: From melt spots to stents
- 20 July 2024
- Published by Elsevier in Optics & Laser Technology
- Vol. 180
Open AccessFabrication of filigree parts via laser powder bed fusion: From melt spots to stents
- Open Access
Remotely Controlled Electrochemical Degradation of Metallic Implants
Biodegradable medical implants promise to benefit patients by eliminating risks and discomfort associated with permanent implantation or surgical removal. The time until full resorption is largely determined by the implant's material composition, geometric design, and surface properties. Implants with a fixed residence time, however, cannot account for the needs of individual patients, thereby imposing limits on personalization. Here, an active Fe‐based implant system is reported whose biodegradation is controlled remotely and in situ. This is achieved by incorporating a galvanic cell within the implant. An external and wireless signal is used to activate the on‐board electronic circuit that controls the corrosion current between the implant body and an integrated counter electrode. This configuration leads to the accelerated degradation of the implant and allows to harvest electrochemical energy that is naturally released by corrosion. In this study, the electrochemical properties of the Fe‐30Mn‐1C/Pt galvanic cell model system is first investigated and high‐resolution X‐ray microcomputed tomography is used to evaluate the galvanic degradation of stent structures. Subsequently, a centimeter‐sized active implant prototype is assembled with conventional electronic components and the remotely controlled corrosion is tested in vitro. Furthermore, strategies toward the miniaturization and full biodegradability of this system are presented.
Open AccessRemotely Controlled Electrochemical Degradation of Metallic Implants
Biodegradable medical implants promise to benefit patients by eliminating risks and discomfort associated with permanent implantation or surgical removal. The time until full resorption is largely determined by the implant's material composition, geometric design, and surface properties. Implants with a fixed residence time, however, cannot account for the needs of individual patients, thereby imposing limits on personalization. Here, an active Fe‐based implant system is reported whose biodegradation is controlled remotely and in situ. This is achieved by incorporating a galvanic cell within the implant. An external and wireless signal is used to activate the on‐board electronic circuit that controls the corrosion current between the implant body and an integrated counter electrode. This configuration leads to the accelerated degradation of the implant and allows to harvest electrochemical energy that is naturally released by corrosion. In this study, the electrochemical properties of the Fe‐30Mn‐1C/Pt galvanic cell model system is first investigated and high‐resolution X‐ray microcomputed tomography is used to evaluate the galvanic degradation of stent structures. Subsequently, a centimeter‐sized active implant prototype is assembled with conventional electronic components and the remotely controlled corrosion is tested in vitro. Furthermore, strategies toward the miniaturization and full biodegradability of this system are presented.
- Open Access
- 22 January 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 7 (2) , 839-852
Inherent Antibacterial Properties of Biodegradable FeMnC(Cu) Alloys for Implant Application
Implant-related infections or inflammation are one of the main reasons for implant failure. Therefore, different concepts for prevention are needed, which strongly promote the development and validation of improved material designs. Besides modifying the implant surface by, for example, antibacterial coatings (also implying drugs) for deterring or eliminating harmful bacteria, it is a highly promising strategy to prevent such implant infections by antibacterial substrate materials. In this work, the inherent antibacterial behavior of the as-cast biodegradable Fe69Mn30C1 (FeMnC) alloy against Gram-negative Pseudomonas aeruginosa and Escherichia coli as well as Gram-positive Staphylococcus aureus is presented for the first time in comparison to the clinically applied, corrosion-resistant AISI 316L stainless steel. In the second step, 3.5 wt % Cu was added to the FeMnC reference alloy, and the microbial corrosion as well as the proliferation of the investigated bacterial strains is further strongly influenced. This leads for instance to enhanced antibacterial activity of the Cu-modified FeMnC-based alloy against the very aggressive, wild-type bacteria P. aeruginosa. For clarification of the bacterial test results, additional analyses were applied regarding the microstructure and elemental distribution as well as the initial corrosion behavior of the alloys. This was electrochemically investigated by a potentiodynamic polarization test. The initial degraded surface after immersion were analyzed by glow discharge optical emission spectrometry and transmission electron microscopy combined with energy-dispersive X-ray analysis, revealing an increase of degradation due to Cu alloying. Due to their antibacterial behavior, both investigated FeMnC-based alloys in this study are attractive as a temporary implant material.
- 22 January 2024
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 7 (2) , 839-852
Open AccessInherent Antibacterial Properties of Biodegradable FeMnC(Cu) Alloys for Implant Application
Implant-related infections or inflammation are one of the main reasons for implant failure. Therefore, different concepts for prevention are needed, which strongly promote the development and validation of improved material designs. Besides modifying the implant surface by, for example, antibacterial coatings (also implying drugs) for deterring or eliminating harmful bacteria, it is a highly promising strategy to prevent such implant infections by antibacterial substrate materials. In this work, the inherent antibacterial behavior of the as-cast biodegradable Fe69Mn30C1 (FeMnC) alloy against Gram-negative Pseudomonas aeruginosa and Escherichia coli as well as Gram-positive Staphylococcus aureus is presented for the first time in comparison to the clinically applied, corrosion-resistant AISI 316L stainless steel. In the second step, 3.5 wt % Cu was added to the FeMnC reference alloy, and the microbial corrosion as well as the proliferation of the investigated bacterial strains is further strongly influenced. This leads for instance to enhanced antibacterial activity of the Cu-modified FeMnC-based alloy against the very aggressive, wild-type bacteria P. aeruginosa. For clarification of the bacterial test results, additional analyses were applied regarding the microstructure and elemental distribution as well as the initial corrosion behavior of the alloys. This was electrochemically investigated by a potentiodynamic polarization test. The initial degraded surface after immersion were analyzed by glow discharge optical emission spectrometry and transmission electron microscopy combined with energy-dispersive X-ray analysis, revealing an increase of degradation due to Cu alloying. Due to their antibacterial behavior, both investigated FeMnC-based alloys in this study are attractive as a temporary implant material.
- Open Access
- 23 December 2021
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (1) , 439-451
Cell–Material Interactions in Direct Contact Culture of Endothelial Cells on Biodegradable Iron-Based Stents Fabricated by Laser Powder Bed Fusion and Impact of Ion Release
Additive manufacturing is a promising technology for the fabrication of customized implants with complex geometry. The objective of this study was to investigate the initial cell–material interaction of degradable Fe-30Mn-1C-0.02S stent structures in comparison to conventional 316L as a reference, both processed by laser powder bed fusion. FeMn-based alloys have comparable mechanical properties with clinically applied AISI 316L for a corrosion-resistant stent material. Different corrosion stages of the as-built Fe-30Mn-1C-0.02S stent surfaces were simulated by pre-conditioning in DMEM under cell culture conditions for 2 h, 7 days, and 28 days. Human umbilical vein endothelial cells (HUVECs) were directly seeded onto the pre-conditioned samples, and cell viability, adherence, and morphology were analyzed. These studies were accompanied by measurements of iron and manganese ion release and Auger electron spectroscopy to evaluate the influence of corrosion products and degradation on the cells. In the initial phase (2 h of pre-conditioning), HUVECs were able to attach but the cell number decreased over the cultivation period of 14 days and the CD31 staining pattern of intercellular contacts was disordered. At later time points of corrosion (7 and 28 days of pre-conditioning), CD31 staining was distinctly located at the intercellular contacts, and the cell density increased after seeding and was stable for up to 14 days. Formation of a complex degradation layer, which had a composition and thickness dependent on the pre-conditioning time, led to a reduced ion release and finally showed a positive effect on cell survival. Concluding, our data suggest the suitability of Fe-30Mn-1C-0.02S for in vivo applications.
- 23 December 2021
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 14 (1) , 439-451
Open AccessCell–Material Interactions in Direct Contact Culture of Endothelial Cells on Biodegradable Iron-Based Stents Fabricated by Laser Powder Bed Fusion and Impact of Ion Release
Additive manufacturing is a promising technology for the fabrication of customized implants with complex geometry. The objective of this study was to investigate the initial cell–material interaction of degradable Fe-30Mn-1C-0.02S stent structures in comparison to conventional 316L as a reference, both processed by laser powder bed fusion. FeMn-based alloys have comparable mechanical properties with clinically applied AISI 316L for a corrosion-resistant stent material. Different corrosion stages of the as-built Fe-30Mn-1C-0.02S stent surfaces were simulated by pre-conditioning in DMEM under cell culture conditions for 2 h, 7 days, and 28 days. Human umbilical vein endothelial cells (HUVECs) were directly seeded onto the pre-conditioned samples, and cell viability, adherence, and morphology were analyzed. These studies were accompanied by measurements of iron and manganese ion release and Auger electron spectroscopy to evaluate the influence of corrosion products and degradation on the cells. In the initial phase (2 h of pre-conditioning), HUVECs were able to attach but the cell number decreased over the cultivation period of 14 days and the CD31 staining pattern of intercellular contacts was disordered. At later time points of corrosion (7 and 28 days of pre-conditioning), CD31 staining was distinctly located at the intercellular contacts, and the cell density increased after seeding and was stable for up to 14 days. Formation of a complex degradation layer, which had a composition and thickness dependent on the pre-conditioning time, led to a reduced ion release and finally showed a positive effect on cell survival. Concluding, our data suggest the suitability of Fe-30Mn-1C-0.02S for in vivo applications.
- Open Access
- 14 July 2015
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 11 (6) , 1710-1722
Modulation of chondrogenic differentiation of human mesenchymal stem cells in jellyfish collagen scaffolds by cell density and culture medium
Studies on tissue-engineering approaches for the regeneration of traumatized cartilage focus increasingly on multipotent human mesenchymal stem cells (hMSCs) as an alternative to autologous chondrocytes. The present study applied porous scaffolds made of collagen from the jellyfish Rhopilema esculentum for the in vitro chondrogenic differentiation of hMSCs. Culture conditions in those scaffolds differ from conditions in high-density pellet cultures, making a re-examination of these data necessary. We systematically investigated the influence of seeding density, basic culture media [Dulbecco's modified Eagle's medium (DMEM), α-minimum essential medium (α-MEM)] with varying glucose content and supplementation with fetal calf serum (FCS) or bovine serum albumin (BSA) on the chondrogenic differentiation of hMSCs. Gene expression analyses of selected markers for chondrogenic differentiation and hypertrophic development were conducted. Furthermore, the production of cartilage extracellular matrix (ECM) was analysed by quantification of sulphated glycosaminoglycan and collagen type II contents. The strongest upregulation of chondrogenic markers, along with the highest ECM deposition was observed in scaffolds seeded with 2.4 × 106 cells/cm3 after cultivation in high-glucose DMEM and 0.125% BSA. Lower seeding densities compared to high-density pellet cultures were sufficient to induce in vitro chondrogenic differentiation of hMSCs in collagen scaffolds, which reduces the amount of cells required for the seeding of scaffolds and thus the monolayer expansion period. Furthermore, examination of the impact of FCS and α-MEM on chondrogenic MSC differentiation is an important prerequisite for the development of an osteochondral medium for simultaneous osteogenic and chondrogenic differentiation in biphasic scaffolds for osteochondral tissue regeneration. Copyright © 2015 John Wiley & Sons, Ltd.
- 14 July 2015
- Published by Wiley in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 11 (6) , 1710-1722
Open AccessModulation of chondrogenic differentiation of human mesenchymal stem cells in jellyfish collagen scaffolds by cell density and culture medium
Studies on tissue-engineering approaches for the regeneration of traumatized cartilage focus increasingly on multipotent human mesenchymal stem cells (hMSCs) as an alternative to autologous chondrocytes. The present study applied porous scaffolds made of collagen from the jellyfish Rhopilema esculentum for the in vitro chondrogenic differentiation of hMSCs. Culture conditions in those scaffolds differ from conditions in high-density pellet cultures, making a re-examination of these data necessary. We systematically investigated the influence of seeding density, basic culture media [Dulbecco's modified Eagle's medium (DMEM), α-minimum essential medium (α-MEM)] with varying glucose content and supplementation with fetal calf serum (FCS) or bovine serum albumin (BSA) on the chondrogenic differentiation of hMSCs. Gene expression analyses of selected markers for chondrogenic differentiation and hypertrophic development were conducted. Furthermore, the production of cartilage extracellular matrix (ECM) was analysed by quantification of sulphated glycosaminoglycan and collagen type II contents. The strongest upregulation of chondrogenic markers, along with the highest ECM deposition was observed in scaffolds seeded with 2.4 × 106 cells/cm3 after cultivation in high-glucose DMEM and 0.125% BSA. Lower seeding densities compared to high-density pellet cultures were sufficient to induce in vitro chondrogenic differentiation of hMSCs in collagen scaffolds, which reduces the amount of cells required for the seeding of scaffolds and thus the monolayer expansion period. Furthermore, examination of the impact of FCS and α-MEM on chondrogenic MSC differentiation is an important prerequisite for the development of an osteochondral medium for simultaneous osteogenic and chondrogenic differentiation in biphasic scaffolds for osteochondral tissue regeneration. Copyright © 2015 John Wiley & Sons, Ltd.